(Q24243163)

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Idiopathic nephrotic syndrome: prevention of early relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Chlorambucil dosage in frequently relapsingnephrotic syndrome: A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Long-term results of two unconventional agents in steroid-dependent nephrotic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Chlorambucil treatment of frequently relapsing nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Therapeutic effect of chai-ling-tang (sairei-to) on the steroid-dependent nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Cyclophosphamide in the treatment of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Eight and 12 week courses of cyclophosphamide in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

The treatment of relapsing primary nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Long-term outcome of primary nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Corticosteroid therapy for nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Corticosteroid therapy for nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Corticosteroid therapy for nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

High dose methylprednisolone therapy in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

The nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

164 children with nephrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Unconjugated hyperbilirubinemia due to ciclosporin administration in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021

Evaluation of alternate-day steroid therapy for nephrotic syndrome in childhood by cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001533.PUB4

7 January 2021